Quantcast Profile: Trellis Bioscience
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Profile: Trellis Bioscience

Posted on 06/25/2007 09:43:41 | Link | Post Comment
BioHealth Investor Company Directory Profile



TRELLIS BIOSCIENCE
2-B Corporate Drive
South San Francisco, CA 94080
Phone: 650.616.1100
Fax: 650.589.4860



The next 21st century breakthrough in monoclonal antibody technology is currently housed at Trellis Bioscience. This South San Francisco company has developed a breakthrough technology platform for cellular informatics. Trellis uses nanotechnology, software and digital microscopy to better locate and recover the original rare favorable cells which will be used to make monoclonal antibodies.

The technology has broad applications in the discovery and production of therapeutic monoclonal antibodies. The Trellis proprietary technology, including patents and know-how, uses nanoparticles in a live cell environment to achieve multiplexing and miniaturization in one step. This capability addresses key bottlenecks in the research and discovery process as well as production, such as:

Elimination of time and resource-intensive cloning and propagation prior to specificity and affinity analysis, and rapid confirmation of clonality after subcloning

Epitope mapping in a comprehensive, efficient manner to assure targeting of the optimal antigen site

Resurrection of failed projects through capture of more favorable, but extremely rare specificities

Selection of high secreting cell populations during manufacturing and scale-up

Characterization and isolation of antibodies from non-transformed populations, making it possible to find rare, highly specific human monoclonal antibodies in a mixed population of human cells from patients and immune donors






This is a BioHealth Investor company profile. Promote your company, learn how...
____________________
Stock Quote or
Examples
Morpheus Trading - Thu Jul 17, 2008 01:15AM
NOTE: Please click on the charts below to enlarge them if th [read more]
Morpheus Trading - Tue Jul 15, 2008 08:25AM
NOTE: Please click on the charts below to enlarge them [read more]
Morpheus Trading - Mon Jul 14, 2008 02:18AM
NOTE: Please click on the charts below to enlarge them if [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.